Nerve agent / organophosphate mass exposure
cholinergic crisis antidote · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Nerve agents and organophosphates inhibit acetylcholinesterase, flooding synapses with acetylcholine and causing a cholinergic crisis. Rapid decontamination, atropine titrated to secretions, oximes, and seizure control are life-saving in a mass-exposure CBRN event.
Red flags
- Copious bronchial secretions and bronchospasm (airway failure)
- Seizures or coma
- Profound bradycardia
- Respiratory muscle weakness
- Multiple simultaneous casualties with miosis and secretions (deliberate release)
Assessment
Differential diagnosis
- Carbamate poisoning
- Other cholinergic toxidrome
- Status epilepticus of other cause
- Opioid toxicity
- Cyanide/asphyxiant exposure
- Mass psychogenic illness
Investigations
- Clinical toxidrome recognition (SLUDGE/DUMBELS, miosis, bronchorrhoea)
- Red cell/plasma cholinesterase activity (confirmatory, not immediate)
- Continuous ECG (bradycardia, QT changes)
- ABG/oxygenation
- Glucose and electrolytes
- Agent identification via hazmat/public health
Management
- Protect responders with appropriate PPE; do not become a secondary casualty
- Remove the casualty from the source and perform decontamination (remove clothing, wash skin) before definitive treatment where possible
- Secure the airway and provide high-flow oxygen; suction copious secretions
- Give atropine and titrate rapidly to drying of bronchial secretions (the key endpoint), not pupil size or heart rate
- Double the atropine dose every few minutes until secretions dry; large cumulative doses are often needed
- Give an oxime (pralidoxime or obidoxime) to reactivate cholinesterase before ageing occurs
- Control seizures and prevent them with a benzodiazepine (e.g. diazepam/midazolam); use auto-injectors in the field
- Support ventilation for respiratory muscle failure
- Manage mass casualties with triage, antidote auto-injectors, and surge capacity
- Monitor for the intermediate syndrome (delayed weakness) and relapse
- Coordinate with hazmat, public health, and law enforcement for a deliberate release
- Continue atropine infusion and oxime as guided until the crisis resolves
Drugs & doses
Atropine 1.2-3 mg IV initial (2 mg in field auto-injectors), doubling every ~5 min until secretions dry
Pralidoxime 1-2 g IV over 15-30 min then infusion (or obidoxime per protocol)
Diazepam 5-10 mg IV or midazolam 10 mg IM for seizures/prophylaxis
Nerve-agent auto-injector (atropine + pralidoxime) in the field
Disposition
ICU with ventilatory support and atropine/oxime infusions; hazmat decontamination before hospital entry; public health and major-incident coordination.
Complications & pitfalls
- Respiratory failure from bronchorrhoea and muscle paralysis
- Intermediate syndrome (delayed proximal weakness)
- Seizures and brain injury
- Aspiration
- Secondary responder contamination
Exam pearls
- Atropine is titrated to drying secretions, not to heart rate or pupils, and huge doses may be required
- Give the oxime early, before the enzyme ages and reactivation becomes impossible
- Decontaminate to protect yourself and the department from secondary exposure
- Benzodiazepines both treat and prevent nerve-agent seizures
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.